top of page

Maria Diletta Pezzani

Medical Doctor

Email:

mariadiletta.pezzani@aovr.veneto.it

Phone:

+39 045 812 8243

Short biography

Diletta has been an Infectious and Tropical Diseases Physician at the University Hospital of Verona since April 2021 and works as an Infectious Diseases consultant. Previously, she worked from April 2018 to April 2021 as a clinical research fellow at University of Verona in the Division of Infectious Diseases. Her scientific interests include antimicrobial stewardship and epidemiology of multidrug resistant bacteria. She is a fellow of the European Society of Infectious Diseases and Clinical Microbiology and (ESCMDI) and of the ESCMID Study Group for Implant-Associated Infections.

Projects

BE READY NOW

AMR Travel Tool

SOLIDARITY-Italy

ORCHESTRA

Excellence Centres

ARCH-NET

ECRAID-Base

WHO BPPL

ABOUT-MDRO

PRIMAVERA

ENSURE

COACH

Publications

27/02/22

Journal of Fungi

Surveillance of antifungal resistance in Candidemia fails to inform antifungal stewardship in European countries

05/12/20

Journal of Antimicrobial Chemotherapy

White Paper: bridging the gap between surveillance data and antimicrobial stewardship in long-term care facilities-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks

05/12/20

Journal of Antimicrobial Chemotherapy

White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks

30/11/20

Journal of Antimicrobial Chemotherapy

Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project

05/12/20

Journal of Antimicrobial Chemotherapy

White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks

31/08/20

Journal of Neurology, Neurosurgery & Psychiatry

Nervous system: subclinical target of SARS-CoV-2 infection

bottom of page